Uploads by MayTepper

J.P. Morgan reiterates OREX with Overweight and $12 price target - May 8

Wells Fargo Note on OREX - Set Up to Be a Transformational Year

JMP Securities Reaffirms Outperform on NAVB and $3PT - May 16

JMP expects U.S. approval of Contrave; reiterates Outperform and $12 PT

Brean Capital Expecting Positive Panel in June; Reiterates PGNX with a BUY and $11PT

JMP Securities Reaffirms Outperform on NAVB and $5PT - May 7